AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal for...
Q1 2026
May 20, 2026
FY 2025
Mar 26, 2026
Q4 2025
Q3 2025
Nov 12, 2025
Q2 2025
Aug 14, 2025